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      Ethosomes are a novel and alternative drug delivery systems and currently the focus of many 
research activities. Ethosomes are soft, flexible vesicles that are composed mainly of phospholipids, 
ethanol and water. Ethosomes can provide better skin permeation than liposomes and deliver enhanced 
amounts of both small and large therapeutic agents through skin and targeting to deeper skin layers for 
various diseases. Finally deliver to the systemic circulation. It is clear that ethosomal carrier because of 
presences ethanol cause skin disruption and increases lipid fluidity. In this review, the mechanism of 
penetration, applications, preparation, advantages and disadvantages of ethosomes are illuminated. 
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INTRODUCTION 
   The skin is a highly specialized structure that 
protects man from his environment. The primary 
function of the skin is to act as a barrier to 
passage of substances into the body. Delivery of 
drugs through the skin has been a most exciting 
as well as a challenging field of research [1]. 
Liposome-based drug delivery system has been 
considered as a promising carrier in which the 
drug is encapsulated securely in the liposome 
particle until it reaches its target cells. However, 
a number of studies have been conducted to 
liposome-based delivery of drugs, enhanced skin 
delivery of drugs can be obtained by novel lipid 
carriers known as ethosomes [2]. 
In recent years, ethosomes have attracted 
increasing attention as a new liposome carriers 
because of their high deformability, high 
enmeshment efficiency, and a great transdermal 
permeation rate in the drug-delivery system [3]. 
Ethosome carriers, developed by Touitou et al., 
are a modified form of liposomes that include a 
relatively high concentration of ethanol. They are 
very efficient at enhancing the skin permeation 
of a number of drugs to reach the deeper layer of 
skin or the systemic circulation [4]. It has been 
shown that the physicochemical characteristics of 
ethosomes permit this vesicular carrier to 
transport active substances more effectively 
through the stratum corneum (SC) into the 
deeper layers of the skin than conventional 
liposomes [5]. 
Structure of ethosomes 
     The main difference between ethosomes and 
liposomes is in their composition. Ethosome 
comprises various types of phospholipid 
structures, water, and low molecular weight 
alcohol (ethanol or isopropyl alcohol) in high 
concentration that provide malleability to the 
vesicle membrane [6]. The ethosomal lipids are 
in a more-fluid state than liposomes containing 
the same ingredients without ethanol. Thus the 
ethanol can act as a “mixing” agent for lipid 
vesicles and provide vesicles with softness 
characteristics, which allow them to increase 
their distribution in different skin layers [7]. 
However, because of their high ethanol 
concentration, the lipid membrane is packed less 
firmly than conventional vesicles but has 
equivalent solidity, allowing a more malleable 
structure and enhance drug distribution ability in 
stratum corneum lipids. In the cases of drugs 
with high solubility, the presence of ethanol in 
ethosomes can exhibit high encapsulation 
efficiency and improved drug loading [8]. 
It has been reported that the decrease of ethanol 
concentration in the range of 20% to 45% can 
result in the increase in the size of ethosomes and 
makes the ethosomes unique [9]. The non-
aqueous phase (alcohol and glycol combination)  
 
 




may range between 22 to 70%.  And polyglycols 
like propylene glycol, transcutol RTM are used 
as skin penetration enhancer. Various 
phospholipids which are used as vesicle forming 
component are phosphatidylcholine (for instance: 
soya phosphatidylcholine, egg phosphatidyl-
choline, dipalmitoyl phosphatidylcholine, 
distearoyl phosphatidylcholine) phosphatidic acid, 
phosphatidylethanolamine, phosphatidylserine,  
phosphatidylglycerol, and phosphatidylinositol 
(PI). In addition, non-ionic surfactants (PEG-
alkyl ethers) can be combined with the 
phospholipids in these preparations. Cationic 
lipids like cocoamide, POE alkyl amines, 
dodecylamine, cetrimide etc can be added too 
[10]. Cholesterol used at a range of 0.1% - 1% 
provide stability to the vesicle membrane.  Such 
a composition enables delivery of high 
concentration of active ingredients through skin. 
Drug delivery can be modulated by altering 
alcohol: water or alcohol-polyol: water ratio . 
In addition, soybean phosphatidylcholine 
(Phospholipon 90), ethanol, drug and distilled 
water can be served for production of 
Ethosomes. Table 1 shows various additives 
employed in preparation of ethosomes [11]. 
Skin 
      In order to understand the mechanism of 
ethosome-based drug delivery system, we must 
first understand the structure of skin and the 
layers that make it up. There are three structural 
layers to the skin: the epidermis, the dermis and 
subcutis. Epidermis is the outermost layer and is 
seen on the surface of the skin. The main cells 
of the epidermis are the keratinocytes, which 
synthesize the protein keratin. The keratinocytes 
develop at the bottom and rise to the top, where 
they are shed from the surface as dead cells 
[12]. 
The outer most portion of the epidermis known 
as the stratum corneum. It consists of 10 to 25 
layers of dead, extended, fully keratinized 
corneocytes, which are inserted in a matrix of 
lipid bilayers. It has been shown that the stratum 
corneum is the main barrier to penetration 
through the skin. It is relatively waterproof and, 
when undamaged, obstructs most bacteria, 
viruses, and other foreign substances from 
entering the body. The keratinocytes in the 
stratum corneum are dead squamous cells that 
are no longer multiplying [12]. 
 
The dermis consists is mostly made of dense 
irregular connective tissue and is much thicker 
than the epidermis. The dermis is responsible 
for the tensile strength of skin. Its main roles are 
to regulate temperature and to supply the 
epidermis with nutrient-saturated blood. Much 
of the body's water supply is storage within the 
dermis [12, 13].  
The subcutaneous layer (It is also called 
hypedermis) lies below the dermis. The 
subcutaneous layer is primarily composed of fat 
and connective tissue.  It performs as a 
protective cushion and helps to insulate the 
body by monitoring heat gain and heat loss. Not 
all authors regard this layer a part of the skin, 
but it definitely has a strong impact on the way 
the skin looks [12, 13]. 
Mechanism of penetration 
     The basic advantage of ethosomes over 
liposomes is the increase permeation of drug. 
The mechanism of penetration of the ethosomes 
in and through the skin is not yet completely 
clear. But it is suggested that the drug 
absorption probably occurs in following two 
phases : 
1. Ethanol effect; according the first 
mechanism, ethosomal formulations contain 
ethanol in their composition that interacts with 
intercellular lipid molecules in the polar head 
group region, thereby increasing their fluidity 
and decreasing the density of the lipid 
multilayer, which results in an increase in 
membrane permeability. 2. Ethosomes effect; 
the high alcohol content is expected to results in 
increased skin permeability. So the ethosomes 
permeates very easily inside the deep skin 
layers, where it got combined with skin lipids 
and releases the drugs into deep layer of skin 
[14].  
Applications of ethosomes 
    In this part of paper, ten applications of 
ethosomes are illuminated:  
1. Hormones delivery; oral administration of 
hormones is connected with issues like high 
first pass metabolism, low oral bioavailability 
and several dose dependent side effects. The 
risk of failure of treatment is known to growth 
with each pill missed [15]. 
2. Antibiotics delivery; topical delivery of 
antibiotics is a convenient option for increasing 









Table 1. Different Additive Employed In preparation of Ethosomes [29-32]. 
 
Conventional oral therapy of antibiotics is often 
seen with several allergic reactions as well as 
side effects and low therapeutic efficacy. 
Regarding topical delivery of antibiotics, 
conventional external preparations have low 
permeability to deep layers of skin and 
subdermal tissues. Ethosomes can overcome 
this problem by delivering adequate quantity of 
antibiotic into deeper skin layers. Ethosomes 
penetrate quickly through the epidermis and 
bring considerable amount of drugs into the 
deeper layer of skin and suppress infection at 
their root. In view of this reason, Godin and 
Touitou prepared bacitracin and erythromycin 
loaded ethosomal formulation for dermal and 
intracellular delivery. They demonstrated that 
the ethosomal formulation of antibiotic could be 
highly efficient and would overcome the 
problems associated with conventional 
treatment [16]. 
3. Delivery of anti-parkinsonism agent; Dayan 
and Touitou prepared ethosomal formulation of 
psychoactive drug trihexyphenidyl 
hydrochloride (THP) and compared its delivery 
with that from classical liposomal formulation. 
THP is a M1 muscarinic receptors antagonist 
and used in the treatment of Parkinson disease. 
The results showed better skin permeation 
potential of ethosomal-THP formulation and its 
use for better management of Parkinson disease 
[17]. 
4 .Transcellular delivery; Touitou et al. 
demonstrated that better intracellular uptake of 
bacitracin, DNA and erythromycin can be 
achieved using CLSM and FACS techniques in 
different cell lines. In comparison with the 
marketed formulation ethosomes can be an 
attractive clinical alternative for anti-HIV 
therapy [18]. 
5. Topical delivery of DNA; ethosomes can be 
used as carrier for gene therapy application that 
require transient expression of genes.  It has 
been demonstrated that better intracellular 
uptake of DNA, better delivery and expression 
of genes in skin cells can be attained by 
ethosomal formulation.  Gupta et al. recently 
have reported immunization potential using 
transfersomal formulation. Hence, better skin 
penetration ability of ethosomes enables the 
possibility of using these dosage forms for 
delivery of immunizing agents [19]. 
6. Anti-arthritis drug delivery; Cannabidol 
(CBD) is a recently developed drug candidate 
for treating rheumatoid arthritis. CBD-
ethosomal formulation for transdermal delivery 
has been prepared by Lodzki et al. Results 
shows considerably increased its skin 
penetration, and hence it’s activity [20]. 
7. Antiviral drug delivery; Zidovudine and 
Acyclovir are two potent antiviral agents.  The 
first one acts on acquired immunodeficiency 
virus and another one is widely used topically 
for treatment of Herpes labialis. It has been 
reported that ethosomes can improve delivery of 
both of these antiviral drugs [21].  
3. Delivery of problematic drug molecules; 
transdermal delivery is a convenient way for 
delivery of peptides and proteins, because oral 
delivery of these large biogenic molecules are 
pretty difficult and have poor permeation. To 
increase permeation and therapeutic efficacy of 
these above molecules, ethosomes is a good 
idea [22]. 
9. Delivery of antifungal drugs; as a vesicular 
carrier system, ethosomes was found to have 
incredible capability of improving transdermal 
permeation of Ketoconazole. Ethosomes offers 
advantages of rapid onset and maximum release 
of drug with reduction of side effects. 
Furthermore, ethosomes do not damage the 
architecture of skin and so, drug is transported 
into the systemic circulation across the 
CLASS EXAMPLE USES 
 
Phospholipid 
Soya phosphatidyl choline, Dipalmityl phosphatidyl choline, 
Egg phosphatidyl choline 
As vesicles forming 
component 
Dye 
Rhodamine red, Rhodamine-123, 6- Carboxy fluorescence, 
Fluorescene Isothiocynate (FITC) 
For characterization study 
Cholesterol Cholesterol 
For providing the stability to 
vesicle membrane 
Vehicle Carbopol D-934 As a gel former 
Polyglycol Propylene glycol, Transcutol RTM 





For providing the softness 
for vesicle membrane 
As a penetration enhancer 
 




undamaged skin. Ethosomal fluconazole gel 
formulation offers better remission from the 
disease and reduces the duration of therapy in 
treatment of candidiasis patients [23]. 
10. Pilosebaceous targeting; Sebaceous glands 
and Hair follicles are being known as 
potentially key elements in the percutaneous 
drug delivery. Also, great consideration has 
been given to using the follicles as transport 
shunts for systemic drug delivery. Ethosomal 
formulation of minoxidil a lipid soluble drug 
used for baldness accumulate into nude mice 
skin two to seven fold higher and thus can be 
used for pilosebaceous targeting for better 
clinical efficacy [24]. 
Preparation 
     There are two methods that are frequently 
used for preparation of ethosomes, cold or hot 
method. These two methods are very simple and 
do not require any sophisticated equipment. 
Figure 1 illustrates both of two methods.  
 
 
Figure 1. Cold and hot methods for preparation of ethosomes. 
 
Advantages and disadvantages 
    In comparison to other transdermal and 
dermal delivery systems, ethosome shows 
essential advantages which make it an ideal 
candidate for drug delivery. The advantages of 
ethosome include: 
1. Increasing efficacy and therapeutic index. 
2. Reduction in toxicity of the encapsulated 
agent. 
3. Improved permeation: Ethosomes are 
efficient method of drug delivery that improve 
permeation of drug through skin.  In contrast 
with deformation liposomes, ethosomes 
improve skin delivery of drugs both under 
occlusive and non-occlusive conditions. 
4. Suitable for large and varied groups: 
Ethosomes are podium for the delivery of large 
and varied group of drugs. It can entrap all 
types of drug molecules such as hydrophilic, 
lipophilic oramphiphilic, peptides, and protein 
molecules . 
5. Safety and Non-toxicity: It contains non-toxic 
raw material in formulation and reduce toxicity 
of the encapsulated agent. 
6. Simplicity of manufacturing: It is relatively 
simple to manufacture with no complicated 
technical investments required for production 
and is available for immediate 
commercialization. 
7. Being non-invasive: The ethosomal drug is 
administrated in semisolid form (gel or cream) 
therefore, presenting high patient compliance. 
8. Acceptability: Ethosomes are approved 
greatly in Pharmaceutical, Veterinary, Cosmetic 
fields and herbal drug technology. 
9. Better stability and solubility: Ethosomes can 
make many drugs more stable and soluble via 
encapsulation of them as compared to 
conventional vesicles. 
10. Smaller size: Ethosomes are relatively 
smaller than other conventional vesicles. 
11. Selective passive targeting: They provide 
selective passive targeting to tumor tissue. 
12. Improvement of pharmacokinetic effect: 
Ethosomes increase pharmacokinetic effect 
(circulation time). 
13. Flexibility to couple with site specific 
ligands: Ethosome is flexible to couple with site 
specific ligands to achieve active targeting [27-
29]. 
Although ethosomes possess many advantages, 
there are certain disadvantages like: 
1.Very low yield so may not be economical. 
2.Percutaneous absorption depends on the 
molecular size of the drug which should be 
rational. 
3.Ethosomal drug delivery system is limited to 
potent drugs and not for drugs that require high 
blood levels. 
4.Skin irritation or dermatitis may occur in 
some patients due to permeation enhancer or the 
excipients used. 
5.Ethosomal administration is not a means to 
achieve rapid bolus type drug input, rather it is 
usually designed to offer slow, sustained drug 
delivery. 
 




6.Adequate solubility of the drug in both 
lipophilic and aqueous environments to reach 
dermal microcirculation and gain access to the 
systemic circulation. 
7.Release of product during transfer from 
organic to water media [30-32]. 
 
CONCLUSION 
     In this paper, we have discussed the 
mechanism of penetration, applications, 
preparation, advantages and disadvantages of 
ethosomes.  It can be concluded that Ethosomes 
provides a number of important benefits 
including improving the drug's efficacy, 
enhancing patient compliance and comfort and 
reducing the total cost of treatment. Various 
hydrophilic drugs, cationic drugs, proteins and 
peptides can be easily administered through 
transdermal route by ethosomal encapsulation. 
So the main advantage is improved therapies. 
The ethosomal technology is safety and 
convenience of use. Important factors that need 
to be considered when developing alternate 
drug delivery systems. 
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